Literature DB >> 26948726

Assessment of comorbidity in lung cancer: How, why, and in whom?

Ajeet Gajra1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26948726     DOI： 10.1016/j.jgo.2016.02.003

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.599


× No keyword cloud information.
  3 in total

1.  Impact of Lifestyle Diseases on Postoperative Complications and Survival in Elderly Patients with Stage I Non-Small Cell Lung Cancer.

Authors:  Sang Seok Jeong; Pil Jo Choi; Jung Hoon Yi; Sung Sil Yoon
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-04-05

2.  Lung cancer patients' comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study.

Authors:  Jasmin Bossert; Marion Ludwig; Pamela Wronski; Jan Koetsenruijter; Katja Krug; Matthias Villalobos; Josephine Jacob; Jochen Walker; Michael Thomas; Michel Wensing
Journal:  NPJ Prim Care Respir Med       Date:  2021-01-28       Impact factor: 2.871

3.  What patients with lung cancer with comorbidity tell us about interprofessional collaborative care across healthcare sectors: qualitative interview study.

Authors:  Jasmin Bossert; Johanna Forstner; Matthias Villalobos; Anja Siegle; Corinna Jung; Nicole Deis; Michael Thomas; Michel Wensing; Katja Krug
Journal:  BMJ Open       Date:  2020-08-04       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.